This study sought to investigate whether hs-cTnT might improve prediction of a composite endpoint including stroke, MI and all-cause mortality in AF patients at an intermediate-risk according to the CHA2DS2-VASc score. The gene discussed is TNNT2; the disease is stroke disorder.